Tobacco control: all research, no action
Menée à partir des données 1990-2019 de 3 625 enquêtes réalisées dans 204 pays, cette étude analyse la prévalence du tabagisme et la part des maladies attribuable au tabac, en fonction de l'âge et du sexe
In a sobering Article in The Lancet, the GBD 2019 Tobacco Collaborators 1 refine methods to estimate the increasing toll of tobacco-attributable morbidity and mortality. The authors analysed data on prevalence of smoking tobacco use from 204 countries and territories between 1990 and 2019, based on information from 3625 self-reported nationally representative surveys. Their analysis, the second to focus on tobacco in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), 2 improves on calculations of prevalence of smoking in adults and tobacco-related disease by adding over 800 data sources for prevalence and directly estimating the impact of smoking from Bayesian meta-regression analyses of 36 health outcomes.